NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ACM Biolabs

ACM Biolabs

Private
SingaporeHealthcare & Life Scienceshttps://acmbiolabs.com/

Last Round

Grant

May 8, 2025

Total Funding Raised

$8.55M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ACM Biolabs is a biotechnology company that develops targeted vaccines and immunotherapies using its proprietary polymer-lipid hybrid nanoparticle delivery platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

drug deliveryvaccine deliverynanocarrierpolymersomelipid-based deliverybiologicsdrug formulationsynthetic vaccinedelivery platformnanotechnologydrug delivery techbiotech platformnanomedicinepayload deliverybiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ACM Biolabs Comparables

Compare ACM Biolabs with similar companies based on industry and business-model similarity.

ACM Biolabs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mana.bio
82%
20Med Therapeutics
81%
Genevant Sciences
81%

ACM Biolabs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 8, 2025
GrantApr 22, 2025
Series AAug 12, 2021
SeedMar 1, 2020
GrantJan 20, 2014

ACM Biolabs Investors

Notable investors and investment history

ACM Biolabs investors
InvestorRounds
Startup SGGrant
CEPIGrant
Ritz Venture CapitalSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Monthly visitors increased 42% MoM.

  • Apr 22, 2025

    $390K grant received from Startup SG.

ACM Biolabs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ACM Biolabs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ACM Biolabs's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore
Employee Range19
Year Founded2013
Last FundingMay 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.